Elevance Health, Inc.ELV

Market cap
$125.5B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Premiums53,97455,97066,11968,39073,38578,86083,64885,42194,173104,109117,373133,229-
Product revenue---------10,38412,65714,978-
Other Income374140414335335,9208,9686,3156,9137,453-
Total operating revenue--------103,141120,808136,943155,660-
Net investment income8037046597246787808679701,0058771,3781,485-
Net (losses) gains on financial instruments----------318-550-
Total revenues58,80260,71171,02473,87479,15784,86390,03992,105104,213121,867138,639156,595-
Benefit expense44,92747,64856,23756,85561,11766,83472,23671,89581,78688,045102,645116,487-
Cost of products sold--------1,9928,95310,89513,035-
Selling, general and administrative expense8,8398,4369,95311,74812,53512,55812,65014,02013,36417,45015,91417,686-
Interest expense419430603601653723739753746784798851-
Amortization of Intangible Assets242239245221230192168358338361441767-
Loss on extinguishment of debt---145-819--282-11-2-36-21--
Total expenses54,44856,75367,18369,50674,52680,30886,07687,03798,228115,629130,714148,826-
Income before income tax expense4,3543,9583,8404,3684,6314,5553,9645,0685,9856,2387,9257,769-
Income tax expense1,4671,311-1,8082,0712,0861211,3181,1781,6661,8301,750-
Net income----------6,0956,019-
Net loss attributable to noncontrolling interests-----------9-6-
Shareholders’ net income2,8872,6472,4902,5702,5602,4703,8433,7504,8074,5726,1046,025-
Earnings Per Share, Basic7.037.358.349.319.739.3914.714.5318.8118.2325.0425.1-
Earnings Per Share, Diluted6.947.258.28.999.389.2114.3514.1918.4717.9824.7324.81-
Dividends per share-11.51.752.52.62.733.23.84.525.125.92